• Targeting PCNA-POLD1 Axis Prevents Pathologic Cardiac Hypert

  2026-05-20

  Pal et al. elucidate a mechanistic link between DNA synthesis pathways and pathologic myocardial hypertrophy, demonstrating that p21-mediated disruption of the PCNA-POLD1 interaction suppresses cardiomyocyte endoreplication and adverse cardiac remodeling. These findings identify the DNA synthesis machinery as a promising therapeutic target for cardiac hypertrophy.

• Homer1a Modulation of Caspase-6 Relieves Inflammatory Pain i

  2026-05-20

  This preclinical study demonstrates that Homer1a suppresses the caspase-6/TNF-alpha signaling axis to alleviate inflammatory pain in the spinal dorsal horn. The findings clarify a mechanistic link between synaptic regulation and neuroimmune signaling, highlighting caspase-6 inhibition as a promising strategy for pain research.

• Reelin-SFK Signaling is Essential for Ketamine’s Antidepress

  2026-05-19

  This study demonstrates that synaptic Reelin signaling, particularly through Apoer2 and Src family kinases (SFKs), is a critical permissive factor for ketamine-induced synaptic plasticity and behavioral changes in the hippocampus. Disruption of this pathway may underlie nonresponsiveness to ketamine in treatment-resistant depression, highlighting a mechanistic link with potential translational implications.

• RSV NS3 Modulates Host Signaling to Balance Pathogenicity

  2026-05-19

  Zhuang et al. (2025) reveal that Rice stripe virus NS3 protein finely adjusts viral pathogenicity and transmission by hijacking host kinase signaling pathways through stage-specific phosphorylation. This work uncovers a co-survival strategy in virus-vector-plant interactions, providing new mechanistic insights for translational research on host-pathogen dynamics.

• PP 2 (AG 1879): Precision Src Kinase Inhibition in Cell Mode

  2026-05-18

  PP 2 (AG 1879) delivers nanomolar-selective inhibition of Src family kinases, enabling researchers to dissect cancer and immune cell signaling with confidence. This guide builds on recent breakthroughs in cytoskeletal signaling, providing actionable workflows, advanced troubleshooting, and direct links to robust experimental evidence.

• Simvastatin (Zocor): Deep Phenotypic Profiling in Cancer and

  2026-05-18

  Explore the multidimensional use of Simvastatin (Zocor) as a cholesterol synthesis inhibitor and apoptosis inducer in liver cancer research. This article uniquely integrates machine learning-based phenotypic profiling, providing actionable insights for advanced assay design.

• Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Hepatic

  2026-05-17

  Explore how the Annexin V-FITC/PI Apoptosis Assay Kit empowers advanced apoptosis detection in liver ischemia-reperfusion injury models. This article uniquely bridges mechanistic insights from recent human peptidomics research with practical assay guidance for translational hepatology.

• Dosage Sensitivity of Loop Extrusion Tunes Genome Folding

  2026-05-16

  This study reveals that the rate of DNA loop extrusion, modulated by cohesin cofactors NIPBL and PDS5, acts as a tunable parameter for genome folding. The findings explain how cells buffer chromatin structure and transcriptional states against genetic disruptions, with implications for understanding cohesinopathies.

• Gentamycin Sulfate: Precision Tool for Bacterial Resistance

  2026-05-15

  Gentamycin Sulfate is a well-characterized aminoglycoside antibiotic used extensively in bacterial protein synthesis research and studies of antibiotic resistance mechanisms. Its irreversible binding to the bacterial 30S ribosomal subunit underpins both its efficacy and its utility as a research tool. High purity and solubility make it a reliable reagent for precise mechanistic investigations.

• Ademetionine (S-Adenosylmethionine): Mechanisms and Protocol

  2026-05-15

  S-Adenosylmethionine (SAM, Ademetionine) is a central methyl donor in epigenetic and metabolic pathways. Its application in methylation reactions in proteins and DNA, as well as in CNS disorder research, is supported by robust biochemical and clinical data. APExBIO’s B3513 product delivers high-purity SAM for reproducible experimental outcomes.

• Z-VEID-FMK: Precision Caspase-6 Inhibition for Antiviral Pat

  2026-05-14

  Explore Z-VEID-FMK, a potent caspase-6 inhibitor, in the context of viral-host apoptotic pathway research. This article uniquely connects mechanistic insights from new virology studies to practical assay optimization, setting it apart from existing resources.

• Rotigotine Hydrochloride: Optimizing Dopamine D2/D3 Agonist

  2026-05-14

  Rotigotine hydrochloride distinguishes itself as a high-affinity dopamine D2/D3 receptor agonist, enabling reproducible neuroprotection and antiparkinsonian activity in both in vitro and in vivo models. This article delivers actionable protocol guidance, troubleshooting strategies, and translational insights for maximizing the compound's impact in dopaminergic signaling and neurodegenerative disease research.

• Ibrutinib-Induced AF Linked to Off-Target CSK Inhibition: Me

  2026-05-13

  This study identifies C-terminal Src kinase (CSK) inhibition as the mechanistic cause of atrial fibrillation (AF) in ibrutinib-treated mice, separating this effect from Bruton tyrosine kinase (BTK) targeting. The findings clarify safety concerns for kinase inhibitor development and highlight the importance of selectivity in drug design and experimental research.

• Solving Adipocyte Gene Delivery Challenges with ATS-9R (C872

  2026-05-13

  This article addresses common laboratory obstacles in targeted gene delivery to adipocytes and demonstrates how ATS-9R (Adipocyte-targeting sequence-9-arginine, SKU C8721) offers reproducible, data-backed solutions. By emphasizing protocol optimization, assay compatibility, and vendor selection, it empowers researchers to enhance workflow reliability and experimental outcomes using this non-viral gene delivery fusion oligopeptide.

• Procainamide Hydrochloride Reduces Cisplatin Liver Toxicity

  2026-05-12

  This study demonstrates that procainamide hydrochloride, beyond its established use as a cardiac sodium channel blocker, significantly reduces cisplatin-induced hepatotoxicity in rats. The chemoprotection appears linked to altered platinum complex formation and subcellular distribution, offering new mechanistic insight for cross-domain research in drug toxicity mitigation.

16421 records 1/1095 page Next 12345 下5页 Last page